294 related articles for article (PubMed ID: 21835542)
21. High Wnt signaling represses the proapoptotic proteoglycan syndecan-2 in osteosarcoma cells.
Dieudonné FX; Marion A; Haÿ E; Marie PJ; Modrowski D
Cancer Res; 2010 Jul; 70(13):5399-408. PubMed ID: 20530678
[TBL] [Abstract][Full Text] [Related]
22. Single-walled carbon nanotube: One specific inhibitor of cancer stem cells in osteosarcoma upon downregulation of the TGFβ1 signaling.
Miao Y; Zhang H; Pan Y; Ren J; Ye M; Xia F; Huang R; Lin Z; Jiang S; Zhang Y; Songyang Z; Zhang Y
Biomaterials; 2017 Dec; 149():29-40. PubMed ID: 28988062
[TBL] [Abstract][Full Text] [Related]
23. Cancer stem cells in osteosarcoma: recent progress and perspective.
Liu B; Ma W; Jha RK; Gurung K
Acta Oncol; 2011 Nov; 50(8):1142-50. PubMed ID: 21718210
[TBL] [Abstract][Full Text] [Related]
24. Salinomycin: A new paradigm in cancer therapy.
Dewangan J; Srivastava S; Rath SK
Tumour Biol; 2017 Mar; 39(3):1010428317695035. PubMed ID: 28349817
[TBL] [Abstract][Full Text] [Related]
25. Degraded iota-carrageenan can induce apoptosis in human osteosarcoma cells via the Wnt/β-catenin signaling pathway.
Jin Z; Han YX; Han XR
Nutr Cancer; 2013; 65(1):126-31. PubMed ID: 23368922
[TBL] [Abstract][Full Text] [Related]
26. The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells.
Kusunoki S; Kato K; Tabu K; Inagaki T; Okabe H; Kaneda H; Suga S; Terao Y; Taga T; Takeda S
Gynecol Oncol; 2013 Jun; 129(3):598-605. PubMed ID: 23500085
[TBL] [Abstract][Full Text] [Related]
27. Isolation and characterisation of cancer stem cells from canine osteosarcoma.
Wilson H; Huelsmeyer M; Chun R; Young KM; Friedrichs K; Argyle DJ
Vet J; 2008 Jan; 175(1):69-75. PubMed ID: 17851099
[TBL] [Abstract][Full Text] [Related]
28. Wnt/β-Catenin Signaling Activates Expression of the Bone-Related Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types.
Vega OA; Lucero CMJ; Araya HF; Jerez S; Tapia JC; Antonelli M; Salazar-Onfray F; Las Heras F; Thaler R; Riester SM; Stein GS; van Wijnen AJ; Galindo MA
J Cell Biochem; 2017 Nov; 118(11):3662-3674. PubMed ID: 28370561
[TBL] [Abstract][Full Text] [Related]
29. Clinical value of signal transducers and activators of transcription 3 (STAT3) gene expression in human osteosarcoma.
Wang YC; Zheng LH; Ma BA; Zhou Y; Zhang MH; Zhang DZ; Fan QY
Acta Histochem; 2011 Jul; 113(4):402-8. PubMed ID: 20546860
[TBL] [Abstract][Full Text] [Related]
30. Apigenin inhibits the proliferation and invasion of osteosarcoma cells by suppressing the Wnt/β-catenin signaling pathway.
Liu X; Li L; Lv L; Chen D; Shen L; Xie Z
Oncol Rep; 2015 Aug; 34(2):1035-41. PubMed ID: 26035210
[TBL] [Abstract][Full Text] [Related]
31. [Inhibitory effect and significance of rapamycin on the mammalian target of rapamycin signaling pathway in osteosarcoma stem cells and osteosarcoma cells].
Liu PY; Zhang WB; Wang J; Shen YH; Wei YY
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):175-80. PubMed ID: 23879996
[TBL] [Abstract][Full Text] [Related]
32. Salinomycin Suppresses Tumorigenicity of Liver Cancer Stem Cells and Wnt/Beta-catenin Signaling.
Liu Q; Sun J; Luo Q; Ju Y; Song G
Curr Stem Cell Res Ther; 2021; 16(5):630-637. PubMed ID: 31971116
[TBL] [Abstract][Full Text] [Related]
33. Isolation of stem-like cells from human MG-63 osteosarcoma cells using limiting dilution in combination with vincristine selection.
Lou N; Wang Y; Sun D; Zhao J; Wang Y; Gao Z
Indian J Biochem Biophys; 2010 Dec; 47(6):340-7. PubMed ID: 21355416
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity.
Gatti M; Solari A; Pattarozzi A; Campanella C; Thellung S; Maniscalco L; De Maria R; Würth R; Corsaro A; Bajetto A; Ratto A; Ferrari A; Daga A; Barbieri F; Florio T
Exp Cell Res; 2018 Feb; 363(1):48-64. PubMed ID: 29305964
[TBL] [Abstract][Full Text] [Related]
35. Salinomycin: a new cancer drug candidate.
Huczynski A
Chem Biol Drug Des; 2012 Mar; 79(3):235-8. PubMed ID: 22145602
[TBL] [Abstract][Full Text] [Related]
36. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of XIAP by AEG35156 in paediatric tumour cells induces apoptosis and sensitises cells to cytotoxic agents.
Holt SV; Brookes KE; Dive C; Makin GW
Oncol Rep; 2011 Apr; 25(4):1177-81. PubMed ID: 21286665
[TBL] [Abstract][Full Text] [Related]
38. Clinical importance of near-diploid tumor stem lines in patients with osteosarcoma of an extremity.
Look AT; Douglass EC; Meyer WH
N Engl J Med; 1988 Jun; 318(24):1567-72. PubMed ID: 3163773
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo.
Liu X; Choy E; Harmon D; Yang S; Yang C; Mankin H; Hornicek FJ; Duan Z
Anticancer Drugs; 2011 Jun; 22(5):444-53. PubMed ID: 21399492
[TBL] [Abstract][Full Text] [Related]
40. Advances in osteosarcoma stem cell research and opportunities for novel therapeutic targets.
Yan GN; Lv YF; Guo QN
Cancer Lett; 2016 Jan; 370(2):268-74. PubMed ID: 26571463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]